CHICAGO, August 02, 2023 Cardio Diagnostics today announced the expansion of its IP portfolio in Australia with Notice of Allowance of Patent Application.
Cardio Diagnostics Holdings Inc , an artificial intelligence-powered precision cardiovascular medicine company, today announced that China’s Patent Office has issued a Notice of Allowance to. | March 2, 2023